�������ýҕ�l

When the U.S. Food and Drug Administration announced earlier this year that it would allow drugstore chains to sell mifepristone, the highly regulated first drug taken in a two-drug regimen for medication abortion, Walgreens and other pharmacy chains eagerly stepped up and said they would go through the required certification process. (3/8)

In the post-Roe world, one of the prime targets of antiabortion activists is medication abortion, a two-drug regimen in which a pregnant person takes mifepristone followed by misoprostol. (3/6)

Patients’ access to lifesaving medicine is under threat because an anti-abortion rights organization sued in federal district court to overrule the Food and Drug Administration’s approval of mifepristone, which has been used to terminate early pregnancies for almost a quarter century in the U.S. If the judge, appointed by the previous federal administration, rules for the plaintiffs, a medicine considered essential by the World Health Organization will become illegal to distribute or use in the U.S. (Anna Calasanti, Tamara Kay and Susan Ostermann, 3/6)

The lawsuit in Texas filed with the goal of removing a common abortion medication, mifepristone, from the market nationwide has the potential to disrupt the drug approval and development system more broadly. This could affect patients’ access to a variety of medications and weaken pharmaceutical companies’ incentives to develop new drugs. (Greer Donley and Rachel Sachs, 3/3)

A ruling expected soon from a Trump-appointed federal judge in Texas could halt the provision of a drug called mifepristone for use in abortions. This would potentially make the drug very difficult to come by in all states — including those where abortion is legal. (Dana M. Johnson, 3/5)

Pharmaceutical lobbyists are once again using scare tactics to mislead the public on our efforts to bring Minnesotans real relief on prescription drug costs. The latest comes from a Washington-based executive claiming "Price controls would harm state's biotech economy" (Opinion Exchange, Feb. 23). (Zack Stephenson and Kelly Morrison, 3/2)

The neighborhood pharmacist has played a critical role in American towns for centuries. People usually see their pharmacists more often than their family doctor. These professionals understand medications, dosages and drug interactions. (Alicia Plemmons, 3/2)

In opposing a fix to the 2022 Inflation Reduction Act, a leading voice in the effort to move the U.S. biopharmaceutical system toward European-style price controls cited “complicated details” in his reasoning for changing the law, adding that “getting it straight is critically important.” (John Stanford, 3/6)